title: Malignancies in women with HIV infection.
abstract: To review current knowledge of different cancer states affecting women with HIV infection.
  
  
  
  With improved survival of persons with HIV in the post-cART era, the landscape of malignancies in this population has greatly changed with fewer AIDS-defining malignancies (ADM) and a growing number of non-AIDS defining malignancies (NADM). Women, however, continue to represent a vulnerable population at risk for certain ADM and NADM such as cervical, anal, and breast cancer. Human papillomavirus-mediated cancers disproportionately burden women in resource-poor settings such as sub-Saharan Africa. For cancers such as Kaposi's sarcoma, lung cancer, liver cancer, and colorectal cancer, women share a lower burden of disease compared with their male counterparts. However, there remains a dearth of evidence characterizing these disease states specifically among women.
  
  
  
  Cancer in women with HIV continues to be a major source of morbidity and mortality worldwide, especially in low-income countries. Screening strategies, primary prevention through vaccination against human papillomavirus and viral hepatitis, and treatment for HIV with combined antiviral therapy remain cornerstones in cancer prevention.
authors.affiliation: aDepartment of Medicine, Section of Infectious Diseases, Atlanta VA Medical Center, Decatur, Georgia bDepartment of Medicine, Section of Infectious Diseases and Health Services Research, Baylor College of Medicine, Houston, Texas, USA.
authors.forename: Nora T
authors.initials: NT
authors.lastname: Oliver
authors.forename: Elizabeth Y
authors.initials: EY
authors.lastname: Chiao
mesh_terms: D055088:Early Detection of Cancer / Q000706:statistics & numerical data; D005260:Female; D014943:Global Health; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D015994:Incidence; D009369:Neoplasms / Q000175:diagnosis / Q000453:epidemiology* / Q000401:mortality / Q000628:therapy; D012307:Risk Factors